<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04265664</url>
  </required_header>
  <id_info>
    <org_study_id>TRAIL</org_study_id>
    <nct_id>NCT04265664</nct_id>
  </id_info>
  <brief_title>Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke</brief_title>
  <acronym>TRAIL</acronym>
  <official_title>Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the feasibility and effectiveness of a lower
      extremity telerehabilitation protocol with aims to improve lower extremity recovery among
      community-living stroke survivors across Canada.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eighty percent of stroke survivors experience some form of motor impairment, such as loss or
      limitation of function in muscle control or movement, or mobility limitation. Regaining
      walking ability is a priority for most and is achieved in approximately 80%. Unfortunately,
      the occurrence of falling while walking is as high as 73% of all people who recover the
      ability to walk post-stroke, with falls often occurring within the first few months of
      returning home from rehabilitation. This highlights the challenges with transitioning to the
      community for continued post-stroke rehabilitation. Unfortunately, due to increasing demand
      on our healthcare and rehabilitation systems and limited service capacity, stroke survivors
      receive minimal to no follow-up rehabilitation after returning to community-living. As a
      result, it is common for stroke survivors to report unmet lower extremity rehabilitation
      needs, and thus ongoing walking/mobility impairment, balance issues, high incidence of falls,
      and difficulties participating in desired social roles.

      The rapid growth in the use of the Internet and personal mobile technologies, including
      computers, smartphones, and tablets has opened up an array of possibilities through which
      patients can remotely access specialized health services, such as telerehabilitation
      supports, while in their homes and communities. The use of technologies to facilitate optimal
      rehabilitation and recovery after stroke is under-utilized in Canada, despite being highly
      recommended in Canadian stroke guidelines, and positive beliefs about its potential among
      people with stroke.

      Objectives:

        1. To examine the feasibility (e.g. safety, recruitment rate, retention rate, fidelity and
           adherence, burden) of a lower extremity telerehabilitation protocol among
           community-living stroke survivors

        2. To estimate the size of effect of TRAIL on clinical outcomes of functional mobility,
           lower extremity strength and motor impairment, functional balance, quality of life,
           balance self-efficacy, and goal attainment among community-living stroke survivors

      Hypotheses:

      The investigators expect that the the telerehabilitation protocol will demonstrate sufficient
      feasibility to support a larger, multisite randomized controlled trial (RCT). The
      investigators also hypothesize that stroke survivors will improve in functional mobility,
      lower extremity strength and motor impairment, functional balance, quality of life, balance
      self-efficacy, and goal attainment following 4-weeks of telerehabilitation with a trained
      therapist

      This feasibility study will use a single group, pre- post- study design trial.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">May 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Single-group, pre-post study design</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline Timed Up and Go (TUG) at 4 weeks</measure>
    <time_frame>Baseline, Post-Intervention (immediately following 4 weeks of intervention)</time_frame>
    <description>Performance walking test to assess functional mobility.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stroke Impact Scale (SIS)</measure>
    <time_frame>Baseline, Post-Intervention (immediately following 4 weeks of intervention)</time_frame>
    <description>Stroke specific, self-reported health status measure. There are 8 domains assessed in this version and each item is rated using a 5-point Likert scale. The patient rates his/her difficulty completing each item from 1 to 5, and lower scores mean greater difficulty to complete the item.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activities-Specific Balance (ABC) Scale</measure>
    <time_frame>Baseline, Post-Intervention (immediately following 4 weeks of intervention)</time_frame>
    <description>Self-reported questionnaire measuring self-efficacy in performing activities without losing balance. The ABC Scale consists of 16 questions that require the patient to rate their confidence on a scale from 0% to 100%. The higher the percentage, the higher level of physical functioning.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tandem Stand</measure>
    <time_frame>Baseline, Post-Intervention (immediately following 4 weeks of intervention)</time_frame>
    <description>Performance measure to assess balance through holding a tandem stance position (up to 10 seconds; alternate positions: semi-tandem or feet together).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Reach</measure>
    <time_frame>Baseline, Post-Intervention (immediately following 4 weeks of intervention)</time_frame>
    <description>Performance measure to assess balance through maximal forward reach (in cm) from a fixed base.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>modified virtual Fugl-Meyer Assessment</measure>
    <time_frame>Baseline, Post-Intervention (immediately following 4 weeks of intervention)</time_frame>
    <description>Performance measure to assess lower extremity impairment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30 second Sit to Stand</measure>
    <time_frame>Baseline, Post-Intervention (immediately following 4 weeks of intervention)</time_frame>
    <description>Performance measure used to assess lower extremity strength.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Goal Attainment Scale</measure>
    <time_frame>Baseline, Post-Intervention (immediately following 4 weeks of intervention)</time_frame>
    <description>An individualized measure involving goal identification, prioritization, and scaling that is standardized to calculate the extent to which a participant's goals are met as a result of the intervention or therapy. Participants rate their goal attainment on a 5-point response scale, ranging from -2 (worse than expected outcome) to +2 (much better outcome), with higher scores indicating a higher degree of goal attainment.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Feasibility Indicator: Recruitment Rate</measure>
    <time_frame>Post-Intervention (immediately following 4 weeks of intervention)</time_frame>
    <description>Number of participants recruited.</description>
  </other_outcome>
  <other_outcome>
    <measure>Feasibility Indicator: Retention Rate</measure>
    <time_frame>Post-Intervention (immediately following 4 weeks of intervention)</time_frame>
    <description>Percentage of participants with post-intervention data.</description>
  </other_outcome>
  <other_outcome>
    <measure>Feasibility Indicator: Perceived Benefit of Telerehabilitation</measure>
    <time_frame>Post-Intervention (immediately following 4 weeks of intervention)</time_frame>
    <description>Satisfaction survey administered at the end of the post-intervention visit.</description>
  </other_outcome>
  <other_outcome>
    <measure>Feasibility Indicator: Treatment Fidelity</measure>
    <time_frame>Post-Intervention (immediately following 4 weeks of intervention)</time_frame>
    <description>Percentage of telerehabilitation sessions attended, exercise completed during telerehabilitation sessions, self-managed exercise plans completed.</description>
  </other_outcome>
  <other_outcome>
    <measure>Feasibility Indicator: Participant Burden</measure>
    <time_frame>Post-Intervention (immediately following 4 weeks of intervention)</time_frame>
    <description>Percentage of participants with pre- and post-assessments.</description>
  </other_outcome>
  <other_outcome>
    <measure>Feasibility Indicator: Participant Burden 2</measure>
    <time_frame>Post-Intervention (immediately following 4 weeks of intervention)</time_frame>
    <description>Duration to complete the assessments.</description>
  </other_outcome>
  <other_outcome>
    <measure>Feasibility Indicator: Assessor Burden</measure>
    <time_frame>Post-Intervention (immediately following 4 weeks of intervention)</time_frame>
    <description>Duration to complete the assessments.</description>
  </other_outcome>
  <other_outcome>
    <measure>Feasibility Indicator: Therapist Burden</measure>
    <time_frame>Post-Intervention (immediately following 4 weeks of intervention)</time_frame>
    <description>Time spent administering the telerehabilitation session.</description>
  </other_outcome>
  <other_outcome>
    <measure>Feasibility Indicator: Ease of Using Equipment</measure>
    <time_frame>Post-Intervention (immediately following 4 weeks of intervention)</time_frame>
    <description>Downtime due to technical issues of tablet and video-conferencing platform.</description>
  </other_outcome>
  <other_outcome>
    <measure>Feasibility Indicator: Processing Time</measure>
    <time_frame>Post-Intervention (immediately following 4 weeks of intervention)</time_frame>
    <description>Time from initial contact to enrolment.</description>
  </other_outcome>
  <other_outcome>
    <measure>Feasibility Indicator: Incidence of Treatment-Emergent Adverse Events (Safety)</measure>
    <time_frame>Post-Intervention (immediately following 4 weeks of intervention)</time_frame>
    <description>Adverse events from the telerehabilitation sessions or assessments.</description>
  </other_outcome>
  <other_outcome>
    <measure>Feasibility Indicator: Treatment Response</measure>
    <time_frame>Post-Intervention (immediately following 4 weeks of intervention)</time_frame>
    <description>Paired sample t-test.</description>
  </other_outcome>
  <other_outcome>
    <measure>Feasibility Indicator: Treatment Effect</measure>
    <time_frame>Post-Intervention (immediately following 4 weeks of intervention)</time_frame>
    <description>Estimate of effect size and variance for future sample size calculations.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Stroke</condition>
  <condition>Stroke, Ischemic</condition>
  <condition>Stroke Hemorrhagic</condition>
  <condition>Cerebral Infarction</condition>
  <condition>Brain Diseases</condition>
  <condition>Central Nervous System Diseases</condition>
  <condition>Cerebral Vascular Disorder</condition>
  <condition>Brain Ischemia</condition>
  <condition>Brain Infarction</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Infarction</condition>
  <arm_group>
    <arm_group_label>Telerehabilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Receives the telerehabilitation protocol</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Telerehabilitation</intervention_name>
    <description>Participants in the telerehabilitation program will receive a graded exercise and self-management intervention. This program will be delivered in a â‰¤2:1 participant:therapist ratio. Each participant grouping will receive two 60-90 minutes telerehabilitation sessions per week for 4 weeks focusing on lower extremity recovery (total 8-12 hours), with a therapist trained in the use of technology for the provision of rehabilitation. Participants will also be asked to complete at least one additional independent self-managed exercise session each week. This independent exercise session will include selected exercises from the telerehabilitation sessions that will be safe to perform without therapist oversight, and jointly agreed upon by the participant and therapist.</description>
    <arm_group_label>Telerehabilitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  19 year of age or older;

          -  Within 18 months of the most recent stroke;

          -  Hemiparesis of the lower extremity;

          -  Able to walk 10m without physical assistance;

          -  Able to tolerate 50 minutes of activity (including rest breaks, as needed);

          -  Have cognitive-communicative ability to participate as per clinical judgement

          -  Able to provide informed consent;

        Exclusion Criteria:

          -  Currently receiving in- or outpatient rehabilitation;

          -  Living in long-term care;

          -  Severe vision or hearing loss;

          -  Other neurological conditions, e.g. Parkinson's disease;

          -  Presence of significant comorbidities (e.g. severe osteoarthritis), pain or other
             symptoms that significantly impact lower extremity function;

          -  Planned surgery that would preclude or affect participation in the protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ada Tang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Brodie Sakakibara, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Park, BSc</last_name>
    <phone>604-714-4108</phone>
    <email>sarah.park@ubc.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of British Columbia</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6T 1Z4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Sarah Park, BSc</last_name>
      <phone>604-714-4108</phone>
      <email>sarah.park@ubc.ca</email>
    </contact>
    <investigator>
      <last_name>Brodie Sakakibara, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ada Tang, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Riverview Health Centre</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3L 2P4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Anuprita Kanitkar</last_name>
      <phone>204-881-3112</phone>
      <email>anuprita.kan@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Dawn Barrett</last_name>
      <phone>204-250-6782</phone>
      <email>dbarrett3@rhc.mb.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Ruth Barclay, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sepideh Pooyania, MD FRCPC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dalhousie University</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 4R2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Melanie Dunlop</last_name>
      <phone>902-473-1401</phone>
      <email>Melanie.Dunlop@nshealth.ca</email>
    </contact>
    <contact_backup>
      <last_name>Judy Lugar</last_name>
      <phone>902-225-6003</phone>
      <email>Judy@lugar.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Marilyn MacKay-Lyons, MScPT PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Parkwood Institute</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6C 5J1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Mitchell Longval</last_name>
      <phone>519-646-6100</phone>
      <phone_ext>42739</phone_ext>
      <email>mitch.longval@sjhc.london.on.ca</email>
    </contact>
    <investigator>
      <last_name>Robert Teasell, MD FRCP(C)</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Health Network</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Evan Foster</last_name>
      <phone>416-597-3422</phone>
      <phone_ext>3362</phone_ext>
      <email>evan.foster@uhn.ca</email>
    </contact>
    <contact_backup>
      <last_name>Olga Yaroslavtseva</last_name>
      <phone>416-876-4823</phone>
      <email>olga.yaroslavtseva@uhn.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Mark Bayley, MD FRCPC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>January 28, 2020</study_first_submitted>
  <study_first_submitted_qc>February 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2020</study_first_posted>
  <last_update_submitted>May 27, 2020</last_update_submitted>
  <last_update_submitted_qc>May 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>Brodie Sakakibara</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Telerehabilitation</keyword>
  <keyword>Lower extremity</keyword>
  <keyword>Stroke</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>Central Nervous System Diseases</mesh_term>
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Brain Infarction</mesh_term>
    <mesh_term>Cerebrovascular Disorders</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Nervous System Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

